Clincosm LogoSign in Get a demo

Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens

Sponsor
Taipei Medical University WanFang Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT01322685
Collaborator
(none)
40
Enrollment
1
Location
11
Duration (Months)
3.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this study is to study the Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens. Subjects are divided into two groups which are health group and Tuberculosis or lung cancer group in order to compare with the difference.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Prospective
    Official Title:
    Development and Application of Rapid Nucleic Acid Diagnostic Kits for Clinical Specimens
    Study Start Date :
    Jul 1, 2010
    Anticipated Study Completion Date :
    Jun 1, 2011

    Arms and Interventions

    Arm Intervention/Treatment
    Health Group
    Tuberculosis Group

    Tuberculosis or lung cancer group

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      17 Years to 90 Years
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      Yes
      Inclusion Criteria:

      • Health group: between 17 to 90 years old

      • Tuberculosis group: people who are tuberculosis or lung cancer patients and between 17 to 90 years old

      Exclusion Criteria:
      • Women subjects are before or after the period within two days

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Taipei Medical University - WanFang Hospital Taipei Taiwan

      Sponsors and Collaborators

      • Taipei Medical University WanFang Hospital

      Investigators

      • Principal Investigator: Kuo-Sheng Hung, Taipei Medical University WanFang Hospital

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT01322685
      Other Study ID Numbers:
      • 99042
      First Posted:
      Mar 24, 2011
      Last Update Posted:
      Mar 24, 2011
      Last Verified:
      Mar 1, 2011
      Keywords provided by , ,
      Tuberculosis
      Lung cancer
      Additional relevant MeSH terms:
      Tuberculosis

      Study Results

      No Results Posted as of Mar 24, 2011